Literature DB >> 19300875

Molecular imaging markers in clinical trials in Alzheimer s disease.

A Nordberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19300875     DOI： 10.1007/s12603-009-0038-5

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN： 1279-7707            Impact factor:   4.075


× No keyword cloud information.
  4 in total

1.  PET imaging of amyloid deposition in patients with mild cognitive impairment.

Authors:  Anton Forsberg; Henry Engler; Ove Almkvist; Gunnar Blomquist; Göran Hagman; Anders Wall; Anna Ringheim; Bengt Långström; Agneta Nordberg
Journal:  Neurobiol Aging       Date:  2007-05-11       Impact factor: 4.673

2.  PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD.

Authors:  A Kadir; T Darreh-Shori; O Almkvist; A Wall; M Grut; B Strandberg; A Ringheim; G Blomquist; B Långström; A Nordberg
Journal:  Neurobiol Aging       Date:  2007-03-26       Impact factor: 4.673

Review 3.  Amyloid imaging in Alzheimer's disease.

Authors:  Agneta Nordberg
Journal:  Neuropsychologia       Date:  2008-04-08       Impact factor: 3.139

4.  Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.

Authors:  Ahmadul Kadir; Niels Andreasen; Ove Almkvist; Anders Wall; Anton Forsberg; Henry Engler; Göran Hagman; Marie Lärksäter; Bengt Winblad; Henrik Zetterberg; Kaj Blennow; Bengt Långström; Agneta Nordberg
Journal:  Ann Neurol       Date:  2008-05       Impact factor: 10.422
  4 in total
  4 in total

1.  Imaging and biomarkers will be used for detection and monitoring progression of early Alzheimer's disease.

Authors:  M W Weiner
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

2.  Use of biomarkers in clinical trials of Alzheimer disease: from concept to application.

Authors:  Liyong Wu; Pedro Rosa-Neto; Serge Gauthier
Journal:  Mol Diagn Ther       Date:  2011-12-01       Impact factor: 4.074

Review 3.  Positron emission tomography radioligands for in vivo imaging of Aβ plaques.

Authors:  N Scott Mason; Chester A Mathis; William E Klunk
Journal:  J Labelled Comp Radiopharm       Date:  2013 Mar-Apr       Impact factor: 1.921

4.  Use of biomarkers in Alzheimer's trials.

Authors:  B Vellas
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.